US Stock MarketDetailed Quotes
CTOR Citius Oncology
- 1.430
- -0.090-5.92%
Close Sep 26 16:00 ET
- 1.390
- -0.040-2.80%
Post 19:43 ET
101.96MMarket Cap-6217P/E (TTM)
1.539High1.300Low164.62KVolume1.530Open1.520Pre Close231.63KTurnover3.13%Turnover RatioLossP/E (Static)71.30MShares49.00052wk High2.12P/B7.51MFloat Cap1.30052wk Low--Dividend TTM5.25MShs Float49.000Historical High--Div YieldTTM15.75%Amplitude1.300Historical Low1.407Avg Price1Lot Size
Citius Oncology Key Stats
Quarterly+Annual
YOY
| (FY)Sep 30, 2023 | (FY)Sep 30, 2022 | |
|---|---|---|
| Total revenue | 0 | 0 |
| Operating revenue | --0 | --0 |
| Cost of revenue | ||
| Gross profit | ||
| Operating expense | 149.58%12.12M | 4.86M |
| Selling and administrative expenses | 451.59%7.88M | --1.43M |
| -General and administrative expense | 451.59%7.88M | --1.43M |
| Research and development costs | 23.71%4.24M | --3.43M |
| Operating profit | -149.58%-12.12M | -4.86M |
| Net non-operating interest income expense | ||
| Other net income (expense) | ||
| Income before tax | -149.58%-12.12M | -4.86M |
| Income tax | 0.00%576K | 576K |
| Net income | -133.72%-12.7M | -5.43M |
| Net income continuous Operations | -133.72%-12.7M | ---5.43M |
| Minority interest income | ||
| Net income attributable to the parent company | -133.72%-12.7M | -5.43M |
| Preferred stock dividends | ||
| Other preferred stock dividends | ||
| Net income attributable to common stockholders | -133.72%-12.7M | -5.43M |
| Basic earnings per share | -133.72%-0.1782 | -0.0763 |
| Diluted earnings per share | -133.72%-0.1782 | -0.0763 |
| Dividend per share | ||
| Currency Unit | USD | USD |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data